Sponsored Ad | NIKKEI FORUM MELBOURNE 2025 - Leaderboard

India: Eris Lifesciences acquires anti-diabetes novel drug Zomelis for $13m

India: Eris Lifesciences acquires anti-diabetes novel drug Zomelis for $13m

Photo: Mint

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter